Clopenthixol: Difference between revisions
Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 306839864 | IUPAC_name = ''(E,Z)''-2-[4-[3-(2-chlorothioxanthen-9-ylidene) propyl]piperazin-1-..." |
m Protected "Clopenthixol": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(One intermediate revision by one other user not shown) | |||
Line 4: | Line 4: | ||
| verifiedrevid = 306839864 | | verifiedrevid = 306839864 | ||
| IUPAC_name = ''(E,Z)''-2-[4-[3-(2-chlorothioxanthen-9-ylidene) propyl]piperazin-1-yl]ethanol | | IUPAC_name = ''(E,Z)''-2-[4-[3-(2-chlorothioxanthen-9-ylidene) propyl]piperazin-1-yl]ethanol | ||
| image = Clopenthixol | | image =Clopenthixol.png | ||
| width = 280 | | width = 280 | ||
| imagename = Clopenthixol | | imagename = Clopenthixol | ||
Line 44: | Line 44: | ||
| InChIKey = WFPIAZLQTJBIFN-UHFFFAOYAW | | InChIKey = WFPIAZLQTJBIFN-UHFFFAOYAW | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Clopenthixol''' ('''Sordinol'''), also known as '''clopentixol''', is a [[typical antipsychotic]] [[drug]] of the [[thioxanthene]] class. It was introduced by [[Lundbeck]] in 1961.<ref name="isbn0-471-89980-1">{{cite book | author = Sneader, Walter | title = Drug discovery: a history | publisher = Wiley | location = New York | year = 2005 | page = 410 | isbn = 0-471-89980-1 | oclc = | doi = | url = http://books.google.com/?id=Cb6BOkj9fK4C&lpg=PA410&pg=PA410#v=onepage}}</ref> | '''Clopenthixol''' ('''Sordinol'''), also known as '''clopentixol''', is a [[typical antipsychotic]] [[drug]] of the [[thioxanthene]] class. It was introduced by [[Lundbeck]] in 1961.<ref name="isbn0-471-89980-1">{{cite book | author = Sneader, Walter | title = Drug discovery: a history | publisher = Wiley | location = New York | year = 2005 | page = 410 | isbn = 0-471-89980-1 | oclc = | doi = | url = http://books.google.com/?id=Cb6BOkj9fK4C&lpg=PA410&pg=PA410#v=onepage}}</ref> | ||
Line 56: | Line 60: | ||
== References == | == References == | ||
{{Reflist}} | {{Reflist|2}} | ||
== External links == | == External links == | ||
Line 62: | Line 66: | ||
{{Antipsychotics}} | {{Antipsychotics}} | ||
[[Category:Piperazines]] | [[Category:Piperazines]] | ||
[[Category:Organochlorides]] | [[Category:Organochlorides]] | ||
[[Category:Alcohols]] | [[Category:Alcohols]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 19:18, 18 August 2015
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H25ClN2OS |
Molar mass | 400.965 g/mol |
3D model (JSmol) | |
| |
(what is this?) (verify) |
WikiDoc Resources for Clopenthixol |
Articles |
---|
Most recent articles on Clopenthixol Most cited articles on Clopenthixol |
Media |
Powerpoint slides on Clopenthixol |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Clopenthixol at Clinical Trials.gov Clinical Trials on Clopenthixol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Clopenthixol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Clopenthixol Discussion groups on Clopenthixol Patient Handouts on Clopenthixol Directions to Hospitals Treating Clopenthixol Risk calculators and risk factors for Clopenthixol
|
Healthcare Provider Resources |
Causes & Risk Factors for Clopenthixol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Clopenthixol (Sordinol), also known as clopentixol, is a typical antipsychotic drug of the thioxanthene class. It was introduced by Lundbeck in 1961.[1]
Clopenthixol is a racemic mixture of cis and trans isomers. Zuclopenthixol, the pure cis isomer, was later introduced by Lundbeck in 1962,[2] and has been much more widely used. Both drugs are equally effective as antipsychotics and have similar adverse effect profiles, but clopenthixol is half as active on a milligram-to-milligram basis and appears to produce more sedation in comparison.[3]
Clopenthixol is not approved for use in the United States.
See also
References
- ↑ Sneader, Walter (2005). Drug discovery: a history. New York: Wiley. p. 410. ISBN 0-471-89980-1.
- ↑ José Miguel Vela; Helmut Buschmann; Jörg Holenz; Antonio Párraga; Antoni Torrens (2007). Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application. Weinheim: Wiley-VCH. p. 516. ISBN 3-527-31058-4.
- ↑ Gravem A, Engstrand E, Guleng RJ (November 1978). "Cis(Z)-clopenthixol and clopenthixol (Sordinol) in chronic psychotic patients. A double-blind clinical investigation". Acta Psychiatr Scand. 58 (5): 384–8. doi:10.1111/j.1600-0447.1978.tb03570.x. PMID 362830.
External links
- Clopenthixol at the US National Library of Medicine Medical Subject Headings (MeSH)
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Articles with changed CASNo identifier
- Articles with changed ChemSpider identifier
- Articles with changed KEGG identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Piperazines
- Organochlorides
- Alcohols
- Drug